Fish oil (Omega-3)

Omega-3's for Canine Cognition: The Background and Evidence Explained

Omega-3 fatty acids, particularly docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), serve as essential structural and functional components of the central nervous system. In the context of the aging brain, a decline in polyunsaturated fatty acid (PUFA) concentrations may be associated with the progression of Canine Cognitive Dysfunction Syndrome (CCDS). DHA is a primary structural lipid in neurons where it assists with many important functions(Araujo et al., 2022). The pathophysiology of CCDS involves chronic neuroinflammation and oxidative stress, which lead to the degradation of these vital lipids(Blanchard et al., 2025). Omega-3 supplementation may help to address these changes by increasing the levels of neuroprotective metabolites, such as neuroprotectin D1, which help to suppress pro-inflammatory cytokines and mitigate the neuronal apoptosis (cell death) triggered by beta-amyloid accumulation(Welty, 2023).

Pharmacologically, the efficacy of omega-3s is highly dependent on dosage and timing, with recent systematic reviews suggesting that benefits are most pronounced when supplementation begins in the early stages of cognitive decline(Vendramini et al., 2025). Clinical trials in aged Beagle dogs have demonstrated that diets enriched with fish oil or oil-rich algae may improve visuospatial function, shape discrimination, and executive performance(Pan et al., 2018a). These effects are often synergistic; omega-3s are frequently administered alongside antioxidants like Vitamin E and C, which protect the unstable fatty acids from oxidation and enhance their anti-inflammatory potential(Blanchard et al., 2025).

Omega-3’s were primarily studied when administered in combination with other compounds, likely indicating a multi-modal approach may be more effective than an individual agent alone(Pan et al., 2018b). There is a hypothesized benefit to combining omega-3’s with CoQ10, a potent antioxidant and important component of mitochondria. Using these in combination may provide a comprehensive approach to mitochondrial membrane stabilization and protection from oxidative stress, a known contributor to progression of cognitive dysfunction. These currently remain theories and further clinical trials are required for evidence-based recommendations.